Baidu
map

2021更新版—2020 NICE指南:前列腺癌(NG.131)

2021-12-15 英国国家卫生与临床优化研究所 NICE官网

2021年12月,英国国家卫生与临床优化研究所 (NICE)更新了前列腺癌指南。指南涵盖了前列腺癌的诊断和管理,2021年12月,专家组更新了危险分层建议,同时对其他建议也做了相应修改。

中文标题:

2021更新版—2020 NICE指南:前列腺癌(NG.131)

英文标题:

NICE guideline [NG131]:Prostate cancer: diagnosis and management

发布日期:

2021-12-15

简要介绍:

2021年12月,英国国家卫生与临床优化研究所 (NICE)更新了前列腺癌指南。指南涵盖了前列腺癌的诊断和管理,2021年12月,专家组更新了危险分层建议,同时对其他建议也做了相应修改。

评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1191323, encodeId=092911913238d, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57de6415950, createdName=ms5000000254917531, createdTime=Wed Feb 09 08:14:40 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085256, encodeId=0f681085256fc, content=危险分层具体更新内容是什么呢?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3971349380, createdName=540663045, createdTime=Tue Dec 28 23:33:23 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082059, encodeId=2e1110820598d, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5455085993, createdName=145c2665m10暂无昵称, createdTime=Mon Dec 20 12:19:46 CST 2021, time=2021-12-20, status=1, ipAttribution=)]
    2022-02-09 ms5000000254917531

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1191323, encodeId=092911913238d, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57de6415950, createdName=ms5000000254917531, createdTime=Wed Feb 09 08:14:40 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085256, encodeId=0f681085256fc, content=危险分层具体更新内容是什么呢?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3971349380, createdName=540663045, createdTime=Tue Dec 28 23:33:23 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082059, encodeId=2e1110820598d, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5455085993, createdName=145c2665m10暂无昵称, createdTime=Mon Dec 20 12:19:46 CST 2021, time=2021-12-20, status=1, ipAttribution=)]
    2021-12-28 540663045

    危险分层具体更新内容是什么呢?

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1191323, encodeId=092911913238d, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57de6415950, createdName=ms5000000254917531, createdTime=Wed Feb 09 08:14:40 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085256, encodeId=0f681085256fc, content=危险分层具体更新内容是什么呢?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3971349380, createdName=540663045, createdTime=Tue Dec 28 23:33:23 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082059, encodeId=2e1110820598d, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5455085993, createdName=145c2665m10暂无昵称, createdTime=Mon Dec 20 12:19:46 CST 2021, time=2021-12-20, status=1, ipAttribution=)]
    2021-12-20 145c2665m10暂无昵称

    谢谢分享

    0

拓展阅读

2010 ACS 前列腺癌早期筛查指南

美国癌症学会(ACS,American Cancer Society) · 2010-03-01

2010CCO 前列腺癌根治性前列腺切除术病理T3或边缘阳性的辅助放射治疗

加拿大安大略癌症治疗中心(CCO,Cancer Care Ontario) · 2010-04-15

ESMO临床实践指南:前列腺癌

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2010-05-01

2008 前列腺癌骨转移临床诊疗专家共识(2008版)

恶性肿瘤骨转移及骨相关疾病临床诊疗专家组 · 2010-05-01

2011EAU前列腺癌诊疗指南

欧洲泌尿外科学会(EAU,European Association of Urology) · 2011-01-01

前列腺癌诊断标准

中华人民共和国卫生部(MINISTRY OF HEALTH OF THE PEOPLE`S REPUBLIC OF CHINA) · 2011-07-01

Baidu
map
Baidu
map
Baidu
map